1-3 of 3
Song-Yi Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1183: A first-in-class and SHP1 allosteric inhibitor, SB8091, shows a good efficacy and safety profile in preclinical models

Jun Gyu Kim, Ki Moon Ryu, Jongho Cho, Dajeong Kim, Dae Hyeon Seong, Kyu Hwan Kim, Ik-Soo Jang, Jeong Yoon Shin, Seo Yoon Jeong, Mi Yeon Jang, Hong Sik Han, Joon Yonug Hwang, Dae Young Lee, Chae Lim Ryu, Song yi Lee, Han Eol Kim, Hyung Ki Lee, Han Young Lee, Tae-Dong Han, SeungMin Yang, Hyounmie Doh
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1183.
https://doi.org/10.1158/1538-7445.AM2024-1183
Published: 22 March 2024
View article titled, Abstract 1183: A first-in-class and SHP1 allosteric inhibitor, SB8091, shows a good efficacy and safety profile in preclinical models
Journal Articles

Abstract 6846: Tumor cell metaplastic programs and failure of T cell remodeling drive resistance and progression to frontline chemoimmunotherapy in advanced gastric cancer

Samuel J. Wright, Minae An, Byung Hoon Min, You Jeong Heo, Milan Parikh, Lynn Bi, Hyuk Lee, Taejun Kim, Song-Yi Lee, Jeonghyeon Moon, Ryan J. Park, Matthew R. Strickland, Woong Yang Park, Won Ki Kang, Kyoung-Mee Kim, Seung Tae Kim, Arnav Mehta, Samuel J. Klempner, Jeeyun Lee
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6846.
https://doi.org/10.1158/1538-7445.AM2024-6846
Published: 22 March 2024
View article titled, Abstract 6846: Tumor cell metaplastic programs and failure of T cell remodeling drive resistance and progression to frontline chemoimmunotherapy in advanced gastric cancer
Journal Articles

DR4-Ser424 O-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death

Hyeonjeong Lee, Yumin Oh, Young-Jun Jeon, Song-Yi Lee, Hyunjoo Kim, Ho-June Lee, Yong-Keun Jung
Journal: Cancer Research
Cancer Res (2019) 79 (11): 2839–2852.
https://doi.org/10.1158/0008-5472.CAN-18-1991
Published: 03 June 2019
View article titled, DR4-Ser424 <em>O</em>-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death
Open the PDF for DR4-Ser424 <em>O</em>-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death in another window
Includes: Supplementary data